IMS oncology expertise is clinically rich and commercially deep, with more than 60 consultants in strategic markets worldwide. Among them are medical doctors and pharmacists, and commercial experts with PhDs in oncology, gene therapy, biochemistry, virology and molecular biology.
- Mike Aristides, Masters, Health Economics
Principal, Health Economics and Outcomes Research
Mike Aristedes manages our Health Economics and Outcomes Research business in Europe. He has more than 17 years of experience in pharmacoeconomics, epidemiology and biostatistics, and has led a variety of HEOR client engagements focused on the oncology market. - Christian Bach, PhD.
Manager, Oncology Competence Centre
Dr. Christian Bach is Head of IMS Health’s Oncology Competence Centre in Germany. He has more than ten years of experience in the pharmaceutical industry and twelve years of experience in oncology—eight of which were in sales with Baxter Healthcare. - Nigel Burrows, Masters, Psychology
Principal, Performance and Promotion Management
Nigel Burrows supports clients in developing pre and post-launch strategies, particularly in the area of oncology, to ensure maximum product penetration into the marketplace. His experience in new product and portfolio development research has covered a broad range of therapy areas across the specialist and GP markets in over 30 countries. - Graham Lewis
Vice President, Pharma Strategy Europe
An Economist by profession, Graham Lewis focuses on strategic issues within the pharmaceutical industry, with particular emphasis on geographical growth opportunities, mergers and acquisitions, portfolio planning and forecasting. He has worked extensively in oncology from early stage compound evaluation through market assessment, strategic planning and business development. - Fil Manuguid, PhD.
Oncology Consultant
Dr. Fil Manuguid is responsible for providing strategic counsel in such areas as market assessment of specific tumor types, oncology drug forecasting, oncology portfolio management, oncology in and out licensing, oncology drug performance management and pricing and reimbursement. She is an active member of ASCO, ESMO, the European Market Research Society, and is a noted author of a numerous articles appearing in high-profile publications such as New Frontiers, Pharmafocus and Biotechnology News. - Pamela Santoni, MBA
Senior Principal, Pricing and Market Access
Pamela Santoni has more than ten years of consulting experience in the pharmaceutical and biotech industries, and is responsible for helping clients gain formulary access using pricing, reimbursement, clinical development and contracting strategies. Within oncology her experience ranges across supportive care, palliative care and primary therapy—including chemotherapies as well as targeted therapies, and orals and IVs, across a range of tumor types. - Simone Seiter, MD, PhD.
Principal
Dr. Simone Seiter works with clients in defining strategies for their franchise and product portfolios, and developing market entry and sales and marketing approaches for the launch of oncology products. She completed a postdoctoral fellowship at the National Cancer Institute/National Institute of Health in the U.S. and her research work in immunology and oncology has been published in many peer reviewed journals including J Exp Med, J Clin Oncol and Cancer Research.
